Delivery Order SPE2DB20D3303-SPE2DB25FA0AY

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price, a ceiling value of $13,327.86, and a period of performance extending through May 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of CAPLYTA 10.5 MG CAPSULE 30S. The contract has a firm fixed price ceiling value of $1,069.11 and a period of performance through February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CAPLYTA 10.5 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price, a ceiling value of $26,628.74, and an ultimate completion date of May 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CAPLYTA 10.5 MG CAPSULE 30S, a prescription medication, at a ceiling value of $10,905.45. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. No set-aside designation was used for this award. Amerisourcebergen holds a significant...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $25,503.44 and a period of performance through May 5, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,836.32 firm-fixed-price contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CAPLYTA 42 MG CAPSULE 30S. The contract has a total ceiling value of $2,504.85 and runs through October 23, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $6,226.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a medication, with an ultimate completion date of April 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $1,920.23. The ultimate completion date for this delivery order is May 19, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.63, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0AY
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of CAPLYTA 10.5 MG CAPSULE 30S, a medication, with a ceiling value of $12,815.81 and a period of performance through June 11, 2025. The contract is a firm-fixed-price type, indicating predetermined pricing, and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:53 PM